African drug testing training
Scientists from the national laboratories of five African nations, including participants from Ethiopia, Ghana, Kenya, Senegal and Sierra Leone, have gathered in Accra, Ghana, Africa, to take part in technical training for detecting substandard and counterfeit medicines.
Scientists from the national laboratories of five African nations, including participants from Ethiopia, Ghana, Kenya, Senegal and Sierra Leone, have gathered in Accra, Ghana, Africa, to take part in technical training for detecting substandard and counterfeit medicines. The training is part of a technical assistance programme announced earlier this year and funded by the US Pharmacopeial Convention, a nonprofit public health organization that sets standards for the identity, quality, purity and strength of prescription and over-the-counter medicines.
Under the programme, the US organization is providing a comprehensive package of pharmaceutical reference standards, documentary standards and technical training to assist these countries in improving the quality of their medicines. The training focuses on three key topics necessary to appropriately test medicines quality — Fundamentals of High Performance Liquid Chromatography, Microbiology and Effectively Using USP–NF (the organization’s drug compendia).
“With inferior medicines threatening the lives of citizens every day in Africa, it is essential for governments to be equipped with the tools necessary to accurately gauge the quality of the medicines circulating in their markets” said Patrick Lukulay, director of the Promoting the Quality of Medicines Program. “Having a team of scientists trained in essential analytical techniques is a fundamental aspect of a well-functioning regulatory system that protects the domestic drug supply,”
This story originally appeared in The Column. Click here to view that issue.
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Metabolomics Analysis of Low Birth-Weight Infants Using UHPLC-MS/MS Following Lipid Emulsion
January 10th 2025A recent study aimed to directly compare the changes in serum metabolites among very low birth-rate (VLBW) infants following the administration of the soybean oil-based lipid emulsion and soybean oil, medium-chain triglycerides, olive oil, and fish oil (SMOF) lipid emulsion using untargeted metabolomics techniques.
Analyzing New Drug Modalities: An ISC 2024 Interview with Kelly Zhang
January 10th 2025At ISC 2024 in Liverpool, United Kingdom, LCGC International interviewed Kelly Zhang of Genentech about her work analyzing new drug modalities, such as mRNA, oligonucleotides, peptides, and cell and gene therapies.
